PL371427A1 - Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych - Google Patents

Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych

Info

Publication number: PL371427A1
Authority: PL; Poland
Prior art keywords: new uses; aminoalkanephosphonic acids; substituted; substituted aminoalkanephosphonic; acids
Prior art date: 2002-04-30

Application number

PL03371427A

Other languages

English (en)

Inventor

Kurt Lingenhöhl

Yves Auberson

Alyson Fox

Hans Ch. Neijt

Hans O. Kalkman

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-30

Filing date

2003-04-29

Publication date

2005-06-13

2002-04-30 Priority claimed from GB0209886A external-priority patent/GB0209886D0/en

2002-04-30 Priority claimed from GB0209889A external-priority patent/GB0209889D0/en

2002-04-30 Priority claimed from GB0209887A external-priority patent/GB0209887D0/en

2002-05-07 Priority claimed from GB0210371A external-priority patent/GB0210371D0/en

2002-05-31 Priority claimed from GB0212760A external-priority patent/GB0212760D0/en

2003-04-29 Application filed by Novartis Ag filed Critical Novartis Ag

2005-06-13 Publication of PL371427A1 publication Critical patent/PL371427A1/pl

Links

239000002253 acid Substances 0.000 title 1
150000007513 acids Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL03371427A 2002-04-30 2003-04-29 Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych PL371427A1 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0209886A GB0209886D0 (en)	2002-04-30	2002-04-30	Organic compounds
GB0209889A GB0209889D0 (en)	2002-04-30	2002-04-30	Organic compounds
GB0209887A GB0209887D0 (en)	2002-04-30	2002-04-30	Organic compounds
GB0210371A GB0210371D0 (en)	2002-05-07	2002-05-07	Organic compounds
GB0212760A GB0212760D0 (en)	2002-05-31	2002-05-31	Organic compounds

Publications (1)

Publication Number	Publication Date
PL371427A1 true PL371427A1 (pl)	2005-06-13

Family

ID=29408096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03371427A PL371427A1 (pl)	2002-04-30	2003-04-29	Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych

Country Status (13)

Country	Link
US (1)	US20060293282A1 (pl)
EP (1)	EP1501518A2 (pl)
JP (2)	JP2005527600A (pl)
KR (1)	KR20040101573A (pl)
CN (1)	CN1649599A (pl)
BR (1)	BR0309611A (pl)
CA (1)	CA2482524A1 (pl)
IL (1)	IL164779A0 (pl)
MX (1)	MXPA04010816A (pl)
NO (1)	NO20045089L (pl)
PL (1)	PL371427A1 (pl)
TW (1)	TW200403066A (pl)
WO (1)	WO2003092701A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0310868D0 (en) *	2003-05-12	2003-06-18	Novartis Ag	Organic compounds
GB0324542D0 (en) *	2003-10-21	2003-11-26	Novartis Ag	Organic compounds
GB0324541D0 (en) *	2003-10-21	2003-11-26	Novartis Ag	Organic compounds
GB0325172D0 (en) *	2003-10-28	2003-12-03	Novartis Ag	Organic compounds
GB0325175D0 (en) *	2003-10-28	2003-12-03	Novartis Ag	Organic compounds
GB0325390D0 (en) *	2003-10-30	2003-12-03	Novartis Ag	Organic compounds
GB0405034D0 (en) *	2004-03-05	2004-04-07	Novartis Ag	Organic compounds
ITMI20071492A1 (it)	2007-07-24	2009-01-25	S I I T Srl Servizio Internazi	"composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba"

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4994467A (en) *	1989-05-31	1991-02-19	Zimmerman Andrew W	Treating autism and other developmental disorders in children with NMDA receptor antagonists
CA2115792C (en) *	1993-03-05	2005-11-01	David J. Mayer	Method for the treatment of pain
GB9400680D0 (en) *	1994-01-14	1994-03-09	Sandoz Ltd	Improvements in or relating to organic compounds
DE4439492A1 (de) *	1994-10-25	1996-05-02	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
WO1996028445A1 (en) *	1995-03-14	1996-09-19	Warner-Lambert Company	Novel glutamate (ampa/kainate) receptor antagonists: n-substituted fused azacycloalkylquinoxalinediones
MY132385A (en) *	1995-08-31	2007-10-31	Novartis Ag	2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
GB9604400D0 (en) *	1996-03-01	1996-05-01	Pfizer Ltd	Compounds useful in therapy
WO1997046539A1 (en) *	1996-06-05	1997-12-11	Warner-Lambert Company	Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
CZ141399A3 (cs) *	1996-10-24	1999-07-14	Novartis Ag	Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
SE508138C2 (sv) *	1996-12-20	1998-08-31	Ericsson Telefon Ab L M	Metod och anordning för anslutning av elektrisk komponent till kretskort
GB9802225D0 (en) *	1998-02-02	1998-04-01	Cerebrus Ltd	Chemical compounds
US6291479B1 (en) *	1998-12-03	2001-09-18	Alcon Manufacturing, Ltd.	Use of NR2B-selective NMDA-receptor antagonists for the treatment of ophthalmic diseases
GB0018272D0 (en) *	2000-07-25	2000-09-13	Vernalis Research Limited	Chemical compounds IV
DE10048969A1 (de) *	2000-08-23	2002-03-14	Mueller Schwefe Gerhard	Verwendung von Flupirtin zur Tinnitusbehandlung
BR0116001A (pt) *	2000-12-07	2004-07-06	Neuromolecular Inc	Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda

2003
- 2003-04-28 TW TW092109911A patent/TW200403066A/zh unknown
- 2003-04-29 JP JP2004500885A patent/JP2005527600A/ja active Pending
- 2003-04-29 CA CA002482524A patent/CA2482524A1/en not_active Abandoned
- 2003-04-29 EP EP03747434A patent/EP1501518A2/en not_active Withdrawn
- 2003-04-29 WO PCT/EP2003/004466 patent/WO2003092701A2/en not_active Ceased
- 2003-04-29 BR BR0309611-4A patent/BR0309611A/pt not_active IP Right Cessation
- 2003-04-29 US US10/512,923 patent/US20060293282A1/en not_active Abandoned
- 2003-04-29 KR KR10-2004-7017470A patent/KR20040101573A/ko not_active Ceased
- 2003-04-29 PL PL03371427A patent/PL371427A1/pl not_active Application Discontinuation
- 2003-04-29 MX MXPA04010816A patent/MXPA04010816A/es unknown
- 2003-04-29 CN CNA038095971A patent/CN1649599A/zh active Pending
2004
- 2004-10-21 IL IL16477904A patent/IL164779A0/xx unknown
- 2004-11-23 NO NO20045089A patent/NO20045089L/no not_active Application Discontinuation
2009
- 2009-01-22 JP JP2009012152A patent/JP2009137995A/ja active Pending

Also Published As

Publication number	Publication date
US20060293282A1 (en)	2006-12-28
CN1649599A (zh)	2005-08-03
MXPA04010816A (es)	2005-03-07
JP2009137995A (ja)	2009-06-25
WO2003092701A2 (en)	2003-11-13
BR0309611A (pt)	2005-02-09
NO20045089L (no)	2004-11-23
JP2005527600A (ja)	2005-09-15
KR20040101573A (ko)	2004-12-02
WO2003092701A3 (en)	2004-04-08
IL164779A0 (en)	2005-12-18
CA2482524A1 (en)	2003-11-13
AU2003232224A1 (en)	2003-11-17
EP1501518A2 (en)	2005-02-02
TW200403066A (en)	2004-03-01

Legal Events

Date	Code	Title	Description
2011-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
EP1487843A4 (en)	2010-03-10	SUBSTITUTED PHENYLACETIC ACIDS
AU2003202924A1 (en)	2003-07-30	Variation of neural-stimulation parameters
AU2003236991A8 (en)	2003-12-19	Representations of processes
EP1549316A4 (en)	2008-04-09	HAMMER OF TFGbeta
IL172617A0 (en)	2006-04-10	Biaryloxymethylarene-carboxylic acids
EP1577280A4 (en)	2006-08-23	DEUTERATION PROCESS
IL165475A0 (en)	2006-01-15	Nitrooxyderivatives of eyclooxygenase-2 inhibitors
PL371427A1 (pl)	2005-06-13	Nowe zastosowania podstawionych kwasów aminoalkanofosfonowych
TWI367754B (en)	2012-07-11	New carboxamide compound
EP1488046A4 (en)	2005-11-23	CONSTRUCTION METHODS
GB0204140D0 (en)	2002-04-10	Production of olefins
GB0230240D0 (en)	2003-02-05	Removal of an acid
AU2003298725A8 (en)	2004-06-23	Preparation of metallotexaphyrins
AU2003238034A1 (en)	2004-01-23	Novel use of imidazotriazinones
HUP0203929D0 (en)	2003-01-28	New use of substituted alkyl-piridazinone derivatives
PL356853A1 (pl)	2004-05-17	Zastosowanie bakteriofagów
PL356465A1 (pl)	2004-04-05	Sposób wytwarzania 17beta-hydroksy-7alfa-metylo-19-nor-17alfa-pregn-5(10)-en-20-yn-3-onu
GB2393207B (en)	2006-04-12	Means of assembly
EP1511485A4 (en)	2006-04-12	NOVEL USES OF I DL / I -TETRAHYDROPALMATIN
SI1509241T1 (sl)	2007-02-28	Nove uporabe cefaibolov
IL165356A0 (en)	2006-01-15	Preparation of 4-haloalkylkylnicotinamides
AU2003224240A1 (en)	2003-10-08	Compounds comprising pseudo-amino acids
SI1537210T1 (sl)	2006-08-31	Lazna oligonukleotidna inhibicija ekspresije CD40
GB0212113D0 (en)	2002-07-03	Manufacture of signs
GB0216838D0 (en)	2002-08-28	Daetection of nucleic acids